| Patent | Date |
|---|
Antibody-drug Conjugates And Uses Thereof
App 20220054648 - Goldenberg; David M. ; et al. | 2022-02-24 |
Efficacy Of Anti-trop-2-sn-38 Antibody Drug Conjugates For Therapy Of Tumors Relapsed/refractory To Checkpoint Inhibitors
App 20210395385 - Govindan; Serengulam V. ; et al. | 2021-12-23 |
Therapy For Metastatic Urothelial Cancer With The Antibody-drug Conjugate, Sacituzumab Govitecan (immu-132)
App 20210393617 - Govindan; Serengulam V. ; et al. | 2021-12-23 |
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
Grant 11,192,955 - Govindan , et al. December 7, 2 | 2021-12-07 |
Immunoconjugates With An Intracellularly-cleavable Linkage
App 20210346511 - Goldenberg; David M. ; et al. | 2021-11-11 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant RE48,751 - Govindan , et al. September 28, 2 | 2021-09-28 |
Antibody-drug conjugates and uses thereof
Grant 11,116,846 - Goldenberg , et al. September 14, 2 | 2021-09-14 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 11,077,201 - Govindan , et al. August 3, 2 | 2021-08-03 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 11,066,468 - Govindan July 20, 2 | 2021-07-20 |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
Grant 11,052,081 - Govindan , et al. July 6, 2 | 2021-07-06 |
Antibody-drug conjugates and uses thereof
Grant 11,052,156 - Goldenberg , et al. July 6, 2 | 2021-07-06 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 11,020,489 - Govindan , et al. June 1, 2 | 2021-06-01 |
Antibody-drug Conjugates And Uses Thereof
App 20210069343 - Goldenberg; David M. ; et al. | 2021-03-11 |
Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
App 20210046185 - Govindan; Serengulam V. ; et al. | 2021-02-18 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 10,918,721 - Govindan , et al. February 16, 2 | 2021-02-16 |
Antibody-drug conjugates and uses thereof
Grant 10,849,986 - Goldenberg , et al. December 1, 2 | 2020-12-01 |
Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
App 20200316054 - Govindan; Serengulam V. ; et al. | 2020-10-08 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20200276325 - Govindan; Serengulam V. ; et al. | 2020-09-03 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 10,751,420 - Govindan , et al. A | 2020-08-25 |
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
Grant 10,744,129 - Goldenberg , et al. A | 2020-08-18 |
Antibody-drug Conjugates And Uses Thereof
App 20200246481 - Kind Code | 2020-08-06 |
Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
Grant 10,709,701 - Govindan , et al. | 2020-07-14 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 10,682,347 - Govindan , et al. | 2020-06-16 |
Antibody-drug conjugates and uses thereof
Grant 10,653,793 - Goldenberg , et al. | 2020-05-19 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20200121805 - Govindan; Serengulam V. ; et al. | 2020-04-23 |
Antibody-drug Conjugates And Uses Thereof
App 20200085968 - Goldenberg; David M. ; et al. | 2020-03-19 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 10,561,738 - Govindan , et al. Feb | 2020-02-18 |
Therapy For Metastatic Urothelial Cancer With The Antibody-drug Conjugate, Sacituzumab Govitecan (immu-132)
App 20190381032 - Govindan; Serengulam V. ; et al. | 2019-12-19 |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
Grant 10,413,539 - Govindan , et al. Sept | 2019-09-17 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20190194318 - Govindan; Serengulam V. | 2019-06-27 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 10,322,193 - Govindan , et al. | 2019-06-18 |
Efficacy Of Anti-trop-2-sn-38 Antibody Drug Conjugates For Therapy Of Tumors Relapsed/refractory To Checkpoint Inhibitors
App 20190177427 - Govindan; Serengulam V. ; et al. | 2019-06-13 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20190167805 - Govindan; Serengulam V. ; et al. | 2019-06-06 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 10,280,220 - Govindan | 2019-05-07 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 10,265,414 - Govindan , et al. | 2019-04-23 |
Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
Grant 10,266,605 - Govindan , et al. | 2019-04-23 |
EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2A-SN-38) IN HLA-DR POSITIVE CANCERS
App 20190083487 - Govindan; Serengulam V. ; et al. | 2019-03-21 |
RS7 Antibodies
App 20190083621 - Govindan; Serengulam V. ; et al. | 2019-03-21 |
Antibody-drug Conjugates And Uses Thereof
App 20190070308 - Goldenberg; David M. ; et al. | 2019-03-07 |
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
Grant 10,206,918 - Govindan , et al. Feb | 2019-02-19 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20190030175 - Govindan; Serengulam V. ; et al. | 2019-01-31 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20190022226 - Govindan; Serengulam V. ; et al. | 2019-01-24 |
Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
App 20190015405 - Govindan; Serengulam V. ; et al. | 2019-01-17 |
RS7 antibodies
Grant 10,179,171 - Govindan , et al. Ja | 2019-01-15 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 10,143,756 - Govindan , et al. De | 2018-12-04 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 10,137,196 - Govindan , et al. November 27, 2 | 2018-11-27 |
Antibody-drug conjugates and uses thereof
Grant 10,130,718 - Goldenberg , et al. November 20, 2 | 2018-11-20 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 10,130,626 - Govindan , et al. November 20, 2 | 2018-11-20 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20180318439 - Govindan; Serengulam V. ; et al. | 2018-11-08 |
RS7 Antibodies
App 20180250406 - Govindan; Serengulam V. ; et al. | 2018-09-06 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 10,064,957 - Govindan , et al. September 4, 2 | 2018-09-04 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 10,034,950 - Govindan , et al. July 31, 2 | 2018-07-31 |
Therapy Of Small-cell Lung Cancer (sclc) With A Topoisomerase-i Inhibiting Antibody-drug Conjugate (adc) Targeting Trop-2
App 20180185351 - Goldenberg; David M. ; et al. | 2018-07-05 |
RS7 antibodies
Grant 9,999,668 - Govindan , et al. June 19, 2 | 2018-06-19 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20180161440 - Govindan; Serengulam V. ; et al. | 2018-06-14 |
RS7 Antibodies
App 20180133322 - Govindan; Serengulam V. ; et al. | 2018-05-17 |
Therapy For Metastatic Urothelial Cancer With The Antibody-drug Conjugate, Sacituzumab Govitecan (immu-132)
App 20180110772 - Govindan; Serengulam V. ; et al. | 2018-04-26 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 9,931,417 - Govindan , et al. April 3, 2 | 2018-04-03 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20180085469 - Govindan; Serengulam V. ; et al. | 2018-03-29 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 9,855,344 - Govindan , et al. January 2, 2 | 2018-01-02 |
RS7 antibodies
Grant 9,849,176 - Govindan , et al. December 26, 2 | 2017-12-26 |
EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2A-SN-38) IN HLA-DR POSITIVE CANCERS
App 20170360770 - Govindan; Serengulam V. ; et al. | 2017-12-21 |
RS7 antibodies
Grant 9,833,511 - Govindan , et al. December 5, 2 | 2017-12-05 |
Efficacy Of Anti-trop-2-sn-38 Antibody Drug Conjugates For Therapy Of Tumors Relapsed/refractory To Checkpoint Inhibitors
App 20170313781 - Govindan; Serengulam V. ; et al. | 2017-11-02 |
Anti-trop-2 Antibody-drug Conjugates And Uses Thereof
App 20170281791 - Govindan; Serengulam V. ; et al. | 2017-10-05 |
RS7 Antibodies
App 20170274079 - Govindan; Serengulam V. ; et al. | 2017-09-28 |
Anti-Trop-2 antibody-drug conjugates and uses thereof
Grant 9,770,517 - Govindan , et al. September 26, 2 | 2017-09-26 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20170266310 - Govindan; Serengulam V. ; et al. | 2017-09-21 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20170266316 - Govindan; Serengulam V. ; et al. | 2017-09-21 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20170239368 - Govindan; Serengulam V. ; et al. | 2017-08-24 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 9,707,300 - Govindan , et al. July 18, 2 | 2017-07-18 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,700,634 - Govindan , et al. July 11, 2 | 2017-07-11 |
Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
Grant 9,694,088 - Govindan , et al. July 4, 2 | 2017-07-04 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20170165370 - Govindan; Serengulam V. ; et al. | 2017-06-15 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,675,706 - Govindan , et al. June 13, 2 | 2017-06-13 |
Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
App 20170151356 - GOVINDAN; Serengulam V. ; et al. | 2017-06-01 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 9,629,926 - Govindan , et al. April 25, 2 | 2017-04-25 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20170028081 - Govindan; Serengulam V. ; et al. | 2017-02-02 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20170014403 - Govindan; Serengulam V. ; et al. | 2017-01-19 |
Antibody-drug Conjugates And Uses Thereof
App 20170014527 - Goldenberg; David M. ; et al. | 2017-01-19 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20170000896 - Govindan; Serengulam V. ; et al. | 2017-01-05 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,522,959 - Govindan , et al. December 20, 2 | 2016-12-20 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,499,631 - Govindan , et al. November 22, 2 | 2016-11-22 |
Antibody-drug conjugates and uses thereof
Grant 9,492,566 - Goldenberg , et al. November 15, 2 | 2016-11-15 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,493,573 - Govindan , et al. November 15, 2 | 2016-11-15 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,493,574 - Govindan , et al. November 15, 2 | 2016-11-15 |
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
Grant 9,486,536 - Govindan , et al. November 8, 2 | 2016-11-08 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,481,732 - Govindan , et al. November 1, 2 | 2016-11-01 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,480,756 - Govindan , et al. November 1, 2 | 2016-11-01 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,475,884 - Govindan , et al. October 25, 2 | 2016-10-25 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20160303253 - Govindan; Serengulam V. ; et al. | 2016-10-20 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20160287722 - Govindan; Serengulam V. | 2016-10-06 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,458,242 - Govindan , et al. October 4, 2 | 2016-10-04 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20160256562 - Govindan; Serengulam V. ; et al. | 2016-09-08 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20160220695 - Govindan; Serengulam V. ; et al. | 2016-08-04 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,388,237 - Govindan July 12, 2 | 2016-07-12 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20160193357 - Govindan; Serengulam V. ; et al. | 2016-07-07 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 9,375,489 - Govindan , et al. June 28, 2 | 2016-06-28 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20160166708 - Govindan; Serengulam V. ; et al. | 2016-06-16 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,345,783 - Govindan , et al. May 24, 2 | 2016-05-24 |
Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
App 20160129140 - Govindan; Serengulam V. ; et al. | 2016-05-12 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20160090413 - Liu; Donglin ; et al. | 2016-03-31 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20160090423 - Govindan; Serengulam V. ; et al. | 2016-03-31 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20160082003 - Govindan; Serengulam V. ; et al. | 2016-03-24 |
Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
Grant 9,283,286 - Govindan , et al. March 15, 2 | 2016-03-15 |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
Grant 9,272,057 - Govindan , et al. March 1, 2 | 2016-03-01 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20160032004 - Govindan; Serengulam V. ; et al. | 2016-02-04 |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
Grant 9,238,084 - Liu , et al. January 19, 2 | 2016-01-19 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,233,172 - Govindan , et al. January 12, 2 | 2016-01-12 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,226,973 - Govindan , et al. January 5, 2 | 2016-01-05 |
Antibody-drug Conjugates And Uses Thereof
App 20150366988 - Goldenberg; David M. ; et al. | 2015-12-24 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,198,978 - Govindan , et al. December 1, 2 | 2015-12-01 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20150306243 - Govindan; Serengulam V. ; et al. | 2015-10-29 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20150283264 - Govindan; Serengulam V. ; et al. | 2015-10-08 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,138,485 - Govindan , et al. September 22, 2 | 2015-09-22 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,133,268 - Govindan September 15, 2 | 2015-09-15 |
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant 9,107,960 - Govindan , et al. August 18, 2 | 2015-08-18 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 9,102,735 - Govindan , et al. August 11, 2 | 2015-08-11 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150216997 - Govindan; Serengulam V. ; et al. | 2015-08-06 |
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
Grant 9,095,628 - Govindan , et al. August 4, 2 | 2015-08-04 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150202320 - Govindan; Serengulam V. ; et al. | 2015-07-23 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150202319 - Govindan; Serengulam V. ; et al. | 2015-07-23 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196662 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196654 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196666 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196665 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196653 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196664 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20150196661 - Govindan; Serengulam V. ; et al. | 2015-07-16 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20150182633 - Govindan; Serengulam V. ; et al. | 2015-07-02 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20150174270 - Govindan; Serengulam V. ; et al. | 2015-06-25 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20150174269 - Govindan; Serengulam V. ; et al. | 2015-06-25 |
Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
App 20150165075 - Govindan; Serengulam V. ; et al. | 2015-06-18 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20150165076 - Liu; Donglin ; et al. | 2015-06-18 |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
Grant 9,028,833 - Govindan , et al. May 12, 2 | 2015-05-12 |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
Grant 9,005,613 - Liu , et al. April 14, 2 | 2015-04-14 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,999,344 - Govindan , et al. April 7, 2 | 2015-04-07 |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
Grant 8,992,931 - Govindan , et al. March 31, 2 | 2015-03-31 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20150038686 - Govindan; Serengulam V. ; et al. | 2015-02-05 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20150018516 - Govindan; Serengulam V. ; et al. | 2015-01-15 |
Anti-trop-2 Antibody-drug Conjugates And Uses Thereof
App 20140377287 - Govindan; Serengulam V. ; et al. | 2014-12-25 |
Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
App 20140369927 - Govindan; Serengulam V. ; et al. | 2014-12-18 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,889,835 - Govindan , et al. November 18, 2 | 2014-11-18 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20140328752 - Govindan; Serengulam V. ; et al. | 2014-11-06 |
Camptothecin-binding moiety conjugates
Grant 8,877,901 - Govindan November 4, 2 | 2014-11-04 |
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
Grant 8,877,202 - Govindan , et al. November 4, 2 | 2014-11-04 |
RS7 Antibodies
App 20140286861 - Govindan; Serengulam V. ; et al. | 2014-09-25 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20140286860 - Govindan; Serengulam V. ; et al. | 2014-09-25 |
Camptothecin-binding moiety conjugates
Grant 8,834,886 - Govindan , et al. September 16, 2 | 2014-09-16 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20140227179 - Liu; Donglin ; et al. | 2014-08-14 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker
App 20140227180 - Govindan; Serengulam V. ; et al. | 2014-08-14 |
Pro-drug Form (p2pdox) Of The Highly Potent 2-pyrrolinodoxorubicin Conjugated To Antibodies For Targeted Therapy Of Cancer
App 20140219956 - Govindan; Serengulam V. ; et al. | 2014-08-07 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20140219914 - Govindan; Serengulam V. ; et al. | 2014-08-07 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,759,496 - Govindan , et al. June 24, 2 | 2014-06-24 |
RS7 antibodies
Grant 8,758,752 - Govindan , et al. June 24, 2 | 2014-06-24 |
Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
App 20140170063 - Govindan; Serengulam V. ; et al. | 2014-06-19 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,741,300 - Govindan , et al. June 3, 2 | 2014-06-03 |
RS7 Antibodies
App 20140120035 - Govindan; Serengulam V. ; et al. | 2014-05-01 |
Camptothecin-Binding Moiety Conjugates
App 20140099258 - Govindan; Serengulam V. ; et al. | 2014-04-10 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20140058067 - Govindan; Serengulam V. ; et al. | 2014-02-27 |
Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
App 20140044640 - Govindan; Serengulam V. ; et al. | 2014-02-13 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20140004078 - Govindan; Serengulam V. | 2014-01-02 |
Camptothecin-binding moiety conjugates
Grant 08617558 - | 2013-12-31 |
Camptothecin-binding moiety conjugates
Grant 8,617,558 - Govindan , et al. December 31, 2 | 2013-12-31 |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
Grant 8,586,050 - Govindan , et al. November 19, 2 | 2013-11-19 |
RS7 antibodies
Grant 8,574,575 - Govindan , et al. November 5, 2 | 2013-11-05 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20130216561 - Govindan; Serengulam V. | 2013-08-22 |
Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
App 20130209356 - Govindan; Serengulam V. ; et al. | 2013-08-15 |
Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
App 20130177526 - Govindan; Serengulam V. ; et al. | 2013-07-11 |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
Grant 8,435,529 - Govindan , et al. May 7, 2 | 2013-05-07 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,425,912 - Govindan April 23, 2 | 2013-04-23 |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
Grant 8,420,086 - Govindan , et al. April 16, 2 | 2013-04-16 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20130090458 - Govindan; Serengulam V. ; et al. | 2013-04-11 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20130072659 - Govindan; Serengulam V. ; et al. | 2013-03-21 |
Camptothecin-Binding Moiety Conjugates
App 20120328564 - Govindan; Serengulam V. ; et al. | 2012-12-27 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20120328634 - Govindan; Serengulam V. | 2012-12-27 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,338,140 - Govindan , et al. December 25, 2 | 2012-12-25 |
Camptothecin-binding moiety conjugates
Grant 8,268,317 - Govindan , et al. September 18, 2 | 2012-09-18 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,268,319 - Govindan September 18, 2 | 2012-09-18 |
RS7 Antibodies
App 20120141372 - Govindan; Serengulam V. ; et al. | 2012-06-07 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20120082617 - Govindan; Serengulam V. ; et al. | 2012-04-05 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20120040431 - Govindan; Serengulam V. ; et al. | 2012-02-16 |
RS7 antibodies
Grant 8,084,583 - Govindan , et al. December 27, 2 | 2011-12-27 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 8,080,250 - Govindan , et al. December 20, 2 | 2011-12-20 |
Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
App 20110305631 - Govindan; Serengulam V. ; et al. | 2011-12-15 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20110293513 - Govindan; Serengulam V. ; et al. | 2011-12-01 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,067,006 - Govindan , et al. November 29, 2 | 2011-11-29 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 7,999,083 - Govindan , et al. August 16, 2 | 2011-08-16 |
Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
App 20110070156 - Govindan; Serengulam V. ; et al. | 2011-03-24 |
Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
Grant 7,833,528 - Griffiths , et al. November 16, 2 | 2010-11-16 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20100233779 - Govindan; Serengulam V. ; et al. | 2010-09-16 |
RS7 Antibodies
App 20100221177 - Govindan; Serengulam V. ; et al. | 2010-09-02 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20100104589 - Govindan; Serengulam V. ; et al. | 2010-04-29 |
Camptothecin-Binding Moiety Conjugates
App 20100015046 - Govindan; Serengulam V. ; et al. | 2010-01-21 |
Immunoconjugates with an Intracellularly-Cleavable Linkage
App 20090291093 - Govindan; Serengulam V. | 2009-11-26 |
Camptothecin-binding moiety conjugates
Grant 7,591,994 - Govindan , et al. September 22, 2 | 2009-09-22 |
Immunoconjugates with an intracellularly-cleavable linkage
Grant 7,585,491 - Govindan September 8, 2 | 2009-09-08 |
Methods for the purification of stable radioiodine conjugates
Grant 7,521,531 - Govindan April 21, 2 | 2009-04-21 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20080171067 - Govindan; Serengulam V. ; et al. | 2008-07-17 |
Camptothecin-Binding Moiety Conjugates
App 20080166363 - Govindan; Serengulam V. ; et al. | 2008-07-10 |
Method for preparing conjugates of proteins and chelating agents
Grant 7,259,249 - Griffiths , et al. August 21, 2 | 2007-08-21 |
Anti-DOTA antibody
Grant 7,230,085 - Griffiths , et al. June 12, 2 | 2007-06-12 |
Multispecific Noncovalent Complexes For Delivery Of Therapeutics
App 20070048227 - Griffiths; Gary L. ; et al. | 2007-03-01 |
Stable radioiodine conjugates and methods of their synthesis
Grant 7,147,856 - Govindan December 12, 2 | 2006-12-12 |
Camptothecin-binding moiety conjugates
App 20060193865 - Govindan; Serengulam V. | 2006-08-31 |
Method for preparing conjugates of proteins and chelating agents
App 20050191239 - Griffiths, Gary L. ; et al. | 2005-09-01 |
Stable radioiodine conjugates and methods for their synthesis
Grant 6,858,705 - Govindan , et al. February 22, 2 | 2005-02-22 |
Stable radioiodine conjugates and methods for their synthesis
Grant 6,818,742 - Govindan , et al. November 16, 2 | 2004-11-16 |
Immunoconjugates with an intracellularly-cleavable linkage
App 20040185053 - Govindan, Serengulam V. | 2004-09-23 |
Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics
App 20040166115 - Griffiths, Gary L. ; et al. | 2004-08-26 |
Stable radioiodine conjugates and methods for their systhesis
App 20040096394 - Govindan, Serengulam V. | 2004-05-20 |
Stable radioiodine conjugates and methods for their synthesis
App 20040086454 - Govindan, Serengulam V. ; et al. | 2004-05-06 |
Stable radioiodine conjugates and methods of their synthesis
App 20040022725 - Govindan, Serengulam V. | 2004-02-05 |
Stable radioiodine conjugates and methods of their synthesis
App 20040018148 - Govindan, Serengulam V. ; et al. | 2004-01-29 |
Stable radioiodine conjugates and methods for their synthesis
Grant 6,663,866 - Govindan December 16, 2 | 2003-12-16 |
Anti-DOTA antibody
App 20030124057 - Griffiths, Gary L. ; et al. | 2003-07-03 |
Stable radioiodine conjugates and methods for their synthesis
Grant 6,558,669 - Govindan , et al. May 6, 2 | 2003-05-06 |
Dota-biotin derivatives
Grant 6,120,768 - Griffiths , et al. September 19, 2 | 2000-09-19 |
Delivery of diagnostic and therapeutic agents to a target site
Grant 5,965,131 - Griffiths , et al. October 12, 1 | 1999-10-12 |
Boron neutron capture therapy using pre-targeting methods
Grant 5,846,741 - Griffiths , et al. December 8, 1 | 1998-12-08 |
Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
Grant 5,746,996 - Govindan , et al. May 5, 1 | 1998-05-05 |
| 